Sequencing.com — Outsmart Your Genes
Knowledge CenterDNA EducationBlog

Decoding Homocystinuria due to MTHFR Deficiency: Understanding, Diagnosis, and Genetic Testing

Medically reviewed by Brandon Colby, MD, last reviewed

Homocystinuria due to MTHFR deficiency

Short answer: Homocystinuria due to MTHFR deficiency is a rare inherited condition in which a severe lack of the MTHFR enzyme causes very high homocysteine. It is different from the common MTHFR C677T and A1298C variants, which are far more common and usually do not cause disease. Diagnosis combines blood and urine homocysteine tests with genetic testing.

Understanding Homocystinuria due to MTHFR Deficiency

Homocystinuria is a rare genetic disorder characterized by an excess of homocysteine, an amino acid, in the blood and urine. This condition can lead to various health complications, including developmental delays, vision problems, and an increased risk of blood clots. One of the primary causes of homocystinuria is a deficiency in the enzyme methylenetetrahydrofolate reductase (MTHFR) (1).

MTHFR deficiency occurs when there are variants in the MTHFR gene, which is responsible for producing the MTHFR enzyme. This enzyme plays a crucial role in the metabolism of folate, a B-vitamin essential for various body functions. Folate insufficiency due to MTHFR deficiency can be bypassed by 5-methyltetrahydrofolate, a bioactive metabolite (2).

Diagnosing Homocystinuria due to MTHFR Deficiency

Diagnosing homocystinuria due to MTHFR deficiency involves a combination of clinical examination, biochemical testing, and genetic testing. Clinical examination may reveal signs and symptoms consistent with homocystinuria, such as developmental delays, vision problems, or blood clotting issues. Biochemical testing, including measuring homocysteine levels in the blood and urine, can help confirm the diagnosis.

Genetic testing is essential for identifying the specific variants in the MTHFR gene responsible for the enzyme deficiency. Novel compound heterozygous variants of the MTHFR gene have been identified in a Chinese family with homocystinuria, expanding the variant spectrum and enhancing genetic counseling and carrier screening applications (3).

Using Genetic Testing for Homocystinuria due to MTHFR Deficiency

Identifying Disease-Causing Variants

Genetic testing can help identify the specific variants in the MTHFR gene responsible for the enzyme deficiency. This information is crucial for understanding the underlying cause of the disorder and can aid in determining the most appropriate treatment options. Additionally, identifying disease-causing variants can help expand the variant spectrum, which is essential for enhancing genetic counseling and carrier screening applications (3).

Carrier Screening and Prenatal Testing

Genetic testing can also be used for carrier screening and prenatal testing. Carrier screening allows individuals who are considering having children to determine if they carry any MTHFR gene variants that could be passed on to their offspring. Prenatal testing can help identify if a developing fetus has inherited any MTHFR gene variants, allowing for early intervention and treatment if necessary.

Guiding Treatment Choices

Genetic testing can provide valuable information for guiding treatment choices for individuals with homocystinuria due to MTHFR deficiency. For example, a pharmacogenetics-based therapy choice may be recommended for patients with folate insufficiency (2). Additionally, early diagnosis and treatment with betaine have been shown to be effective in a 16-year-old male diagnosed with MTHFR enzyme deficiency presenting as leukodystrophy with spastic paraparesis (4).

Monitoring Treatment Effectiveness

Genetic testing can also be used to monitor the effectiveness of treatment for homocystinuria due to MTHFR deficiency. By tracking changes in the levels of homocysteine and other relevant biomarkers, healthcare providers can assess the efficacy of treatment and make adjustments as needed.

In conclusion, understanding, diagnosing, and using genetic testing for homocystinuria due to MTHFR deficiency are essential for providing optimal care for individuals with this rare genetic disorder. Genetic testing plays a crucial role in identifying disease-causing variants, guiding treatment choices, and monitoring treatment effectiveness. As our understanding of the MTHFR gene and its associated variants continues to grow, so too will our ability to provide targeted and effective therapies for those affected by this condition.

Get Tested With Whole Genome Sequencing

Whole genome sequencing reads 100% of your DNA, including over 30,000 genes, so it reads the whole MTHFR gene and not only the two common variants. Your data also includes other genes involved in folate and homocysteine metabolism. Every Sequencing Kit Bundle includes Next Gen Disease Screening, which analyzes your genome for more than 15,000 conditions. A genetic result is not a diagnosis, so talk with a clinician or genetic counselor before acting on it.

Shop All Whole Genome Sequencing Kit Bundles

Frequently Asked Questions

What is homocystinuria due to MTHFR deficiency?

It is a rare inherited metabolic condition in which the body makes too little working MTHFR enzyme, so homocysteine builds up in the blood and urine. It can cause developmental delay, neurological problems and blood clots, and a metabolic specialist manages it.

How is it different from the common MTHFR variants?

The common variants, C677T and A1298C, lower enzyme activity only a little and are carried by many healthy people. Severe MTHFR deficiency comes from two rare disease causing variants, one inherited from each parent, and leaves very little enzyme activity.

How is it diagnosed?

Doctors measure homocysteine and related compounds in blood and urine and confirm the cause with genetic testing of the MTHFR gene. Genetic results also support carrier screening and counseling for relatives.

How is it treated?

A metabolic specialist guides treatment. Betaine, which helps lower homocysteine, has been used, and the research cited on this page also describes bypassing the missing enzyme with a bioactive form of folate (5-methyltetrahydrofolate).

Sources and Patient Organizations

This page is for education and is not medical advice. Genetic results show risk and do not diagnose a condition. Talk with a clinician or genetic counselor about your results.

Related Articles